Episode 43: Spoilt for choice - the many treatments now available for AMD and DME
Talking Euretina - A podcast by Whipsmart Media
Categories:
Following the approval of Aflibercept 8mg, clinicians in Europe now have 5 anti-VEGF treatments to choose from, not to mention biosimilars. How should we treat patients with so many options open to us? Sandrine Zweifel (Switzerland) and Stela Vujosevic (Italy) compare notes
